Related Experiment Video
Updated: Mar 28, 2026

Author Spotlight: Unraveling the Interplay Between Trichoderma stromaticum and the Mammalian Immune System
Published on: October 20, 2023
Trichosporon asahii urinary tract infection in immunocompetent patients
Inam Danish Khan1, Ajay Kumar Sahni2, Atoshi Basu3
1Clinical Microbiologist, Dept of Pathology, Command Hospital (Eastern Command), Kolkata 700027, India.
Abstract:
Trichosporonosis is an emerging infection predominantly caused by Trichosporon asahii which is a ubiquitous and exclusively anamorphic yeast. T. asahii urinary tract infection is rare and remains scantily reported. T. asahii was isolated from urine of two immunocompetent patients who were receiving in-patient treatment for multiple comorbidities. T. asahii was identified phenotypically by a combination of manual and automated systems. Antifungal susceptibility done by E-test revealed multiresistance with preserved susceptibility to voriconazole. The ubiquity and biofilm formationposes difficulty in establishing pathogenicity and delineating environmental or nosocomial infections. Risk factors such as prolonged multiple antimicrobials, indwelling catheter and comorbidities such as anemia and hypoalbuminemia may be contributory to the establishment of a nosocomial opportunistic T. asahii infection. Dedicated efforts targeted at infection control are needed to optimize management and control of Trichosporon infections.
Insights
Trichosporon asahii urinary tract infections are rare in immunocompetent patients. Voriconazole showed effectiveness against this multidrug-resistant yeast, highlighting infection control needs.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Trichosporonosis, caused by Trichosporon asahii, is an emerging infection.
- Urinary tract infections due to T. asahii are rare and poorly documented.
- T. asahii is a ubiquitous, anamorphic yeast known for its opportunistic nature.
Purpose of the Study:
- To report a rare case of T. asahii urinary tract infection in immunocompetent patients.
- To characterize the antifungal susceptibility profile of the isolated T. asahii strains.
- To discuss potential risk factors and implications for infection control.
Main Methods:
- Isolation and phenotypic identification of T. asahii from urine samples.
- Antifungal susceptibility testing using E-test.
- Clinical data review of two immunocompetent patients with comorbidities.
Main Results:
- T. asahii was identified in urine of two immunocompetent patients with multiple comorbidities.
- The yeast exhibited multidrug resistance but remained susceptible to voriconazole.
- Potential risk factors included prolonged antimicrobial use, indwelling catheters, anemia, and hypoalbuminemia.
Conclusions:
- T. asahii urinary tract infections, though rare, can occur in immunocompetent individuals with risk factors.
- Voriconazole is a potential therapeutic option for T. asahii infections.
- Enhanced infection control measures are crucial for managing Trichosporon infections.
More Related Videos
Related Concept Videos
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection I: Introduction
Urinary Tract Infection IV: Nursing Management
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Microsporidia

